梅萨拉胺诱导的异性肺炎
Monish Sharma1, Joseph E Sotelo2, Steve Schultz3
1Radiology, Texas College of Osteopathic Medicine, Fort Worth, USA.
Cureus
|November 14, 2025
概括
梅萨拉胺可以引起异性肺炎,这是一个罕见的肺部疾病. 这一案例突出显示梅萨拉是潜在的原因,在药物停用后症状会消失.
科学领域:
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 异性肺炎是一种由外周血液异性定义的肺部疾病.
- 原因包括异常,传染性和非传染性触发因素,如药物.
- 常见的毒品罪祸首是达普托米辛,芬伊托因和尼托福兰托因.
研究的目的:
- 报告一种罕见的单边乙性肺炎病例.
- 调查梅萨拉治疗与异性肺炎之间的潜在联系.
- 强调考虑药物诱导原因的重要性.
主要方法:
- 一个27岁的男性患者的病例报告.
- 审查患者病史,症状和药物使用情况 (治疗性结肠炎的美沙胺).
- 在停止服用梅萨拉后,临床观察症状的消失.
主要成果:
- 患者在三个月的梅萨拉治疗后发展出单边的异性肺炎.
- 停用梅萨拉导致症状迅速消失.
- 这支持梅萨拉胺作为致病剂.
结论:
- 梅沙胺诱导的性肺炎是一种罕见但可信的诊断.
- 临床医生应考虑在患有eosinophilic肺炎的患者中使用mesalamine.
- 及时识别和药物取消对于患者的康复至关重要.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
01:29Drugs for Treatment of Ulcerative Colitis in IBD
439
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
439
01:19Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
01:29Pneumonia II: Pathophysiology
2.5K
The pathophysiology of pneumonia involves the following steps:
2.5K
01:30Pneumonia I: Introduction
712
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
712
01:30Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K